---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-22-035802"
form_type: "8-K"
ticker: "ITIC"
cik: "0000720858"
company_name: "INVESTORS TITLE CO"
filed_at: "2022-10-03T23:59:59+00:00"
generated_at: "2026-06-23T06:09:33.270952+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Investors Title extends poison pill to 2032, raises purchase price to $525

## Summary
- Rights agreement extended from Oct 31, 2022 to Sep 30, 2032.
- Purchase price increased from $220 to $525 per one-hundredth of a preferred share.
- New 'Acting in Concert' definition triggers rights when parties act together to influence control.
- Other technical and conforming changes made to the agreement.

## SEC filing metadata
- accession: 0001140361-22-035802
- form_type: 8-K
- ticker: ITIC
- cik: 0000720858
- company_name: INVESTORS TITLE CO
- filed_at: 2022-10-03T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 1.01, 3.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/720858/000114036122035802/0001140361-22-035802-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/720858/000114036122035802/brhc10041897_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-22-035802
- JSON: https://secwatch.observer/filing/0001140361-22-035802.json
- Plain text: https://secwatch.observer/filing/0001140361-22-035802.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.